Arcutis Biotherapeutics, Inc. (ARQT)

NASDAQ

$32.35

$-0.40

(-1.22%)

Regular Market

Arcutis Biotherapeutics, Inc. (ARQT) Live Price Chart

Last updated: ⁦2026-10-21 16:12:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Arcutis Biotherapeutics, Inc. (ARQT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $32.35, with a market capitalization of $4.01B and a P/E ratio of 144.65. Over the past 52 weeks, its price has ranged from $19.30 to $33.30. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$4.01B
Open	$32.65
Day's High	$40.88
Day's Low	$1.76
Previous Close	$32.82
Volume	449.86K
Average Volume	2.44M
P/E Ratio	144.65
52-Week High	$33.30
52-Week Low	$19.30
Dividend Yield	--
Earnings Date	--

Arcutis Biotherapeutics, Inc. (ARQT) Stock Price Today

Arcutis Biotherapeutics, Inc. (ARQT) is currently trading at $32.35 as of 2026-10-21 16:11:00, down 1.44% ($0.47) from the previous close of $32.82

During today's regular trading session, ARQT has traded between $1.76 and $40.88, with a trading volume of 449.86K shares. The current price is near the upper end of today's range.

Arcutis Biotherapeutics, Inc. (ARQT) 7-Day Stock Price Change

Over the past seven days, Arcutis Biotherapeutics, Inc. (ARQT) moved from $26.22 to $32.35, representing a gain of 23.36% ($6.13).

The stock traded between $25.60 and $33.30 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 3.02 million shares, up versus the previous seven-day period, indicating higher trading activity.

ARQT 52-Week Price Position

Position in Range: 93.2%

52W Low$19.30

52W High$33.30

ARQT is currently trading at $32.35, placing it 93.2% of the way from its 52-week low of $19.30 to its 52-week high of $33.30. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Arcutis Biotherapeutics, Inc. (ARQT)?

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Arcutis Biotherapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	354
Exchange	NASDAQ
Company Website	https://www.arcutis.com

How to Buy Arcutis Biotherapeutics, Inc. (ARQT) Stock on MEXC

Eligible investors can buy real shares of Arcutis Biotherapeutics, Inc. (ARQT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ARQT and Place Your Order

Open the RealStocks trading page and search for ARQT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Arcutis Biotherapeutics, Inc. (ARQT) stock price today?

Arcutis Biotherapeutics, Inc. (ARQT) is currently trading at $ 32.35, down 1.44% ($0.47) from the previous close of $ 32.82. Intraday prices update in real time during regular trading hours.

2.Is ARQT stock going up or down today?

As of 2026-10-21 16:11:00, ARQT is trading at $ 32.35, down 1.44% ($0.47) from its previous close of $ 32.82. The stock has traded between $ 1.76 and $ 40.88 during today’s regular session. Past price movements do not guarantee future results.

3.What is ARQT pre-market price?

As of 2026-10-21 16:11:00, ARQT is trading at $ 33.01 in pre-market trading, up 0.59% ($0.19) from the previous close of $ 32.82. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ARQT after-hours price?

As of 2026-10-21 16:11:00, ARQT is trading at $ 32.51 in after-hours trading, down 0.94% ($0.31) from the regular-session close of $ 32.82. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ARQT stock trading now?

ARQT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ARQT sit relative to its 52-week high and low?

Over the past 52 weeks, ARQT has traded between a low of $ 19.30 and a high of $ 33.30. At $ 32.35, the stock is positioned 93.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Arcutis Biotherapeutics, Inc. in?

Arcutis Biotherapeutics, Inc. (ARQT) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Arcutis Biotherapeutics, Inc.'s market capitalization and where is it listed?

Arcutis Biotherapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 4.01B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ARQT valued in terms of P/E ratio and EPS?

ARQT trades at a P/E ratio of 144.65, based on trailing-twelve-month EPS of $ 0.23. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Arcutis Biotherapeutics, Inc. pay a dividend?

Arcutis Biotherapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.